Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | INSM | SRPT | ||
| Company | Biomarin Pharmaceuticals | Insmed Inc | Sarepta Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 66.32 | 73.00 | 132.40 | ||
| High | 67.30 | 73.49 | 133.00 | ||
| Low | 65.75 | 71.57 | 117.57 | ||
| Last | 66.94 | 71.69 | 120.42 | ||
| Change | +0.79 | -1.17 | -7.55 | ||
| % Change | +1.19% | -1.61% | -5.90% | ||
| Volume | 1,350,278 | 1,095,420 | 2,355,790 | ||
| 20-Day Average Volume | 1,497,394 | 1,228,241 | 859,089 | ||
| Previous Close | 66.15 | 72.86 | 127.97 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 68.80 | 72.05 | 126.63 | ||
| 20-Day Raw Stochastic | 28.24% | 48.85% | 18.05% | ||
| 20-Day Relative Strength | 35.53% | 49.65% | 41.29% | ||
| Weighted Alpha | -26.89 | +40.06 | +18.41 | ||
| Today's Opinion | 100% Sell | 8% Sell | 64% Sell | ||
| Previous Opinion | 100% Sell | 40% Buy | 24% Sell | ||
| Last Month's Opinion | 100% Sell | 40% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.59% since 10/31/24 | +6.55% since 10/31/24 | -4.43% since 10/31/24 | ||
| Low | 65.45 on 11/05/24 | 65.95 on 11/01/24 | 117.57 on 11/07/24 | ||
| High | 67.64 on 11/06/24 | 74.00 on 11/06/24 | 133.00 on 11/07/24 | ||
| 1-Month | |||||
| %Chg | -2.93% since 10/07/24 | +1.69% since 10/07/24 | +2.23% since 10/07/24 | ||
| Low | 65.35 on 10/31/24 | 65.95 on 11/01/24 | 116.17 on 10/09/24 | ||
| High | 70.98 on 10/25/24 | 77.70 on 10/16/24 | 133.36 on 10/25/24 | ||
| 3-Month | |||||
| %Chg | -22.43% since 08/07/24 | +0.99% since 08/07/24 | -14.02% since 08/07/24 | ||
| Low | 65.35 on 10/31/24 | 65.95 on 11/01/24 | 116.17 on 10/09/24 | ||
| High | 94.85 on 08/20/24 | 80.53 on 08/22/24 | 144.22 on 08/22/24 | ||
| 6-Month | |||||
| %Chg | -18.94% since 05/07/24 | +174.88% since 05/07/24 | -11.48% since 05/07/24 | ||
| Low | 65.35 on 10/31/24 | 21.92 on 05/24/24 | 109.91 on 05/28/24 | ||
| High | 94.85 on 08/20/24 | 80.53 on 08/22/24 | 173.25 on 06/21/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,607,065 | 13,034,871 | 12,203,986 | ||
| Shares Outstanding, K | 190,583 | 178,903 | 95,366 | ||
| Annual Sales | 2,419,230,000 | 305,210,000 | 1,243,340,000 | ||
| Annual Net Income | 167,650,000 | -749,570,000 | -535,980,000 | ||
| Last Quarter Sales | 745,740,000 | 93,430,000 | 362,930,000 | ||
| Last Quarter Net Income | 106,080,000 | -220,520,000 | 6,460,000 | ||
| 60-Month Beta | 0.31 | 1.12 | 0.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.91 on 10/29/24 | -1.27 on 10/31/24 | 0.62 on 11/06/24 | ||
| Latest Earnings Date | 10/29/24 | 10/31/24 | 11/06/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 29.22 | 0.00 | 271.76 | ||